Uptake of HIV Pre-Exposure Prophylaxis (PrEP) in a National Cohort of Gay and Bisexual Men in the United States
OBJECTIVES:The HIV care cascade provides milestones to track the progress of HIV-positive people from seroconversion through viral suppression. We propose a Motivational pre-exposure prophylaxis (PrEP) Cascade involving 5 stages based on the Transtheoretical Model of Change. METHODS:We analyzed data...
Gespeichert in:
Veröffentlicht in: | Journal of acquired immune deficiency syndromes (1999) 2017-03, Vol.74 (3), p.285-292 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 292 |
---|---|
container_issue | 3 |
container_start_page | 285 |
container_title | Journal of acquired immune deficiency syndromes (1999) |
container_volume | 74 |
creator | Parsons, Jeffrey T Rendina, H Jonathon Lassiter, Jonathan M Whitfield, Thomas H F Starks, Tyrel J Grov, Christian |
description | OBJECTIVES:The HIV care cascade provides milestones to track the progress of HIV-positive people from seroconversion through viral suppression. We propose a Motivational pre-exposure prophylaxis (PrEP) Cascade involving 5 stages based on the Transtheoretical Model of Change.
METHODS:We analyzed data from 995 men in One Thousand Strong, a longitudinal study of a national panel of HIV-negative gay and bisexual men in the United States.
RESULTS:Nearly all (89%) participants were sexually active in the past 3 months and 65% met Centers for Disease Control criteria for PrEP candidacy. Of those identified as appropriate candidates, 53% were Precontemplative (stage 1; unwilling to take or believing they were inappropriate candidates for PrEP) and 23% were in Contemplation (stage 2; willing and self-identified as appropriate candidates). Only 11% were in PrEParation (stage 3; seeing PrEP as accessible and planning to initiate PrEP) and 4% were in PrEP Action (stage 4; prescribed PrEP). Although few of those who were identified as appropriate candidates were on PrEP, nearly all PrEP users (98%) reported adhering to 4 or more doses per week and most (72%) were returning for recommended quarterly medical visits, resulting in 9% of PrEP candidates reaching Maintenance and Adherence (stage 5).
CONCLUSIONS:The large majority of participants were appropriate candidates for PrEP, yet fewer than 1 in 10 were using and adherent to PrEP. These findings highlight the need for interventions tailored to address the unique barriers men face at each stage of the cascade, particularly at the earliest stages where the most dramatic losses were identified. |
doi_str_mv | 10.1097/QAI.0000000000001251 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1877828653</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4315397311</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4598-a8a41e7ee5e6a1ea0cf0673ed0c4f05efde3578a1659d8efd9ad2967777892ac3</originalsourceid><addsrcrecordid>eNqNkU1v1DAQhi0EoqXlHyBkiUt7SLFjO3aOZbVtVyqwFSxXa0gmStpsHGxH3f33OLR8qCfmYo_8zCONX0LecHbGWanf35yvztg_xXPFn5FDXkqZaWPk83RXucokF-qAvArhNjGFlOVLcpAbbjQz8pC4zRjhDqlr6NXqG117zJa70YXJY2rc2O572HWBnqz9cn1Ku4EC_QSxcwP0dOFa5-M8ewl7CkNNP3QBd1N6-ojDDMcW6WboItb0S4SI4Zi8aKAP-PrxPCKbi-XXxVV2_flytTi_ziqpSpOBAclRIyosgCOwqmGFFlizSjZMYVOjUNoAL1RZm9SWUOdloVOZModKHJGTB-_o3Y8JQ7TbLlTY9zCgm4JN-2uTm0KJ_0ALrVSeC5nQd0_QWzf59BW_qDI5OWOJkg9U5V0IHhs7-m4Lfm85s3N2NmVnn2aXxt4-yqfvW6z_DP0O66_33vURfbjrp3v0tkXoY2tnSyGEzHLGNROMs2xWG_EToI6hfQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1869877100</pqid></control><display><type>article</type><title>Uptake of HIV Pre-Exposure Prophylaxis (PrEP) in a National Cohort of Gay and Bisexual Men in the United States</title><source>Journals@Ovid Ovid Autoload</source><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>Free E- Journals</source><creator>Parsons, Jeffrey T ; Rendina, H Jonathon ; Lassiter, Jonathan M ; Whitfield, Thomas H F ; Starks, Tyrel J ; Grov, Christian</creator><creatorcontrib>Parsons, Jeffrey T ; Rendina, H Jonathon ; Lassiter, Jonathan M ; Whitfield, Thomas H F ; Starks, Tyrel J ; Grov, Christian</creatorcontrib><description>OBJECTIVES:The HIV care cascade provides milestones to track the progress of HIV-positive people from seroconversion through viral suppression. We propose a Motivational pre-exposure prophylaxis (PrEP) Cascade involving 5 stages based on the Transtheoretical Model of Change.
METHODS:We analyzed data from 995 men in One Thousand Strong, a longitudinal study of a national panel of HIV-negative gay and bisexual men in the United States.
RESULTS:Nearly all (89%) participants were sexually active in the past 3 months and 65% met Centers for Disease Control criteria for PrEP candidacy. Of those identified as appropriate candidates, 53% were Precontemplative (stage 1; unwilling to take or believing they were inappropriate candidates for PrEP) and 23% were in Contemplation (stage 2; willing and self-identified as appropriate candidates). Only 11% were in PrEParation (stage 3; seeing PrEP as accessible and planning to initiate PrEP) and 4% were in PrEP Action (stage 4; prescribed PrEP). Although few of those who were identified as appropriate candidates were on PrEP, nearly all PrEP users (98%) reported adhering to 4 or more doses per week and most (72%) were returning for recommended quarterly medical visits, resulting in 9% of PrEP candidates reaching Maintenance and Adherence (stage 5).
CONCLUSIONS:The large majority of participants were appropriate candidates for PrEP, yet fewer than 1 in 10 were using and adherent to PrEP. These findings highlight the need for interventions tailored to address the unique barriers men face at each stage of the cascade, particularly at the earliest stages where the most dramatic losses were identified.</description><identifier>ISSN: 1525-4135</identifier><identifier>EISSN: 1944-7884</identifier><identifier>DOI: 10.1097/QAI.0000000000001251</identifier><identifier>PMID: 28187084</identifier><identifier>CODEN: JDSRET</identifier><language>eng</language><publisher>United States: Copyright Wolters Kluwer Health, Inc. All rights reserved</publisher><subject>Adult ; AIDS/HIV ; Gays & lesbians ; HIV ; HIV Infections - prevention & control ; Human immunodeficiency virus ; Humans ; Intervention ; Lentivirus ; Longitudinal Studies ; Male ; Medical treatment ; Middle Aged ; Patient Compliance ; Pre-Exposure Prophylaxis - statistics & numerical data ; Retroviridae ; Sexual and Gender Minorities ; United States</subject><ispartof>Journal of acquired immune deficiency syndromes (1999), 2017-03, Vol.74 (3), p.285-292</ispartof><rights>Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.</rights><rights>Copyright Lippincott Williams & Wilkins Mar 1, 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4598-a8a41e7ee5e6a1ea0cf0673ed0c4f05efde3578a1659d8efd9ad2967777892ac3</citedby><cites>FETCH-LOGICAL-c4598-a8a41e7ee5e6a1ea0cf0673ed0c4f05efde3578a1659d8efd9ad2967777892ac3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00126334-201703010-00008$$EHTML$$P50$$Gwolterskluwer$$H</linktohtml><link.rule.ids>314,776,780,4595,27901,27902,65206</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28187084$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Parsons, Jeffrey T</creatorcontrib><creatorcontrib>Rendina, H Jonathon</creatorcontrib><creatorcontrib>Lassiter, Jonathan M</creatorcontrib><creatorcontrib>Whitfield, Thomas H F</creatorcontrib><creatorcontrib>Starks, Tyrel J</creatorcontrib><creatorcontrib>Grov, Christian</creatorcontrib><title>Uptake of HIV Pre-Exposure Prophylaxis (PrEP) in a National Cohort of Gay and Bisexual Men in the United States</title><title>Journal of acquired immune deficiency syndromes (1999)</title><addtitle>J Acquir Immune Defic Syndr</addtitle><description>OBJECTIVES:The HIV care cascade provides milestones to track the progress of HIV-positive people from seroconversion through viral suppression. We propose a Motivational pre-exposure prophylaxis (PrEP) Cascade involving 5 stages based on the Transtheoretical Model of Change.
METHODS:We analyzed data from 995 men in One Thousand Strong, a longitudinal study of a national panel of HIV-negative gay and bisexual men in the United States.
RESULTS:Nearly all (89%) participants were sexually active in the past 3 months and 65% met Centers for Disease Control criteria for PrEP candidacy. Of those identified as appropriate candidates, 53% were Precontemplative (stage 1; unwilling to take or believing they were inappropriate candidates for PrEP) and 23% were in Contemplation (stage 2; willing and self-identified as appropriate candidates). Only 11% were in PrEParation (stage 3; seeing PrEP as accessible and planning to initiate PrEP) and 4% were in PrEP Action (stage 4; prescribed PrEP). Although few of those who were identified as appropriate candidates were on PrEP, nearly all PrEP users (98%) reported adhering to 4 or more doses per week and most (72%) were returning for recommended quarterly medical visits, resulting in 9% of PrEP candidates reaching Maintenance and Adherence (stage 5).
CONCLUSIONS:The large majority of participants were appropriate candidates for PrEP, yet fewer than 1 in 10 were using and adherent to PrEP. These findings highlight the need for interventions tailored to address the unique barriers men face at each stage of the cascade, particularly at the earliest stages where the most dramatic losses were identified.</description><subject>Adult</subject><subject>AIDS/HIV</subject><subject>Gays & lesbians</subject><subject>HIV</subject><subject>HIV Infections - prevention & control</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Intervention</subject><subject>Lentivirus</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Medical treatment</subject><subject>Middle Aged</subject><subject>Patient Compliance</subject><subject>Pre-Exposure Prophylaxis - statistics & numerical data</subject><subject>Retroviridae</subject><subject>Sexual and Gender Minorities</subject><subject>United States</subject><issn>1525-4135</issn><issn>1944-7884</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1v1DAQhi0EoqXlHyBkiUt7SLFjO3aOZbVtVyqwFSxXa0gmStpsHGxH3f33OLR8qCfmYo_8zCONX0LecHbGWanf35yvztg_xXPFn5FDXkqZaWPk83RXucokF-qAvArhNjGFlOVLcpAbbjQz8pC4zRjhDqlr6NXqG117zJa70YXJY2rc2O572HWBnqz9cn1Ku4EC_QSxcwP0dOFa5-M8ewl7CkNNP3QBd1N6-ojDDMcW6WboItb0S4SI4Zi8aKAP-PrxPCKbi-XXxVV2_flytTi_ziqpSpOBAclRIyosgCOwqmGFFlizSjZMYVOjUNoAL1RZm9SWUOdloVOZModKHJGTB-_o3Y8JQ7TbLlTY9zCgm4JN-2uTm0KJ_0ALrVSeC5nQd0_QWzf59BW_qDI5OWOJkg9U5V0IHhs7-m4Lfm85s3N2NmVnn2aXxt4-yqfvW6z_DP0O66_33vURfbjrp3v0tkXoY2tnSyGEzHLGNROMs2xWG_EToI6hfQ</recordid><startdate>20170301</startdate><enddate>20170301</enddate><creator>Parsons, Jeffrey T</creator><creator>Rendina, H Jonathon</creator><creator>Lassiter, Jonathan M</creator><creator>Whitfield, Thomas H F</creator><creator>Starks, Tyrel J</creator><creator>Grov, Christian</creator><general>Copyright Wolters Kluwer Health, Inc. All rights reserved</general><general>Lippincott Williams & Wilkins Ovid Technologies</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7T5</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>7U2</scope></search><sort><creationdate>20170301</creationdate><title>Uptake of HIV Pre-Exposure Prophylaxis (PrEP) in a National Cohort of Gay and Bisexual Men in the United States</title><author>Parsons, Jeffrey T ; Rendina, H Jonathon ; Lassiter, Jonathan M ; Whitfield, Thomas H F ; Starks, Tyrel J ; Grov, Christian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4598-a8a41e7ee5e6a1ea0cf0673ed0c4f05efde3578a1659d8efd9ad2967777892ac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>AIDS/HIV</topic><topic>Gays & lesbians</topic><topic>HIV</topic><topic>HIV Infections - prevention & control</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Intervention</topic><topic>Lentivirus</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Medical treatment</topic><topic>Middle Aged</topic><topic>Patient Compliance</topic><topic>Pre-Exposure Prophylaxis - statistics & numerical data</topic><topic>Retroviridae</topic><topic>Sexual and Gender Minorities</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Parsons, Jeffrey T</creatorcontrib><creatorcontrib>Rendina, H Jonathon</creatorcontrib><creatorcontrib>Lassiter, Jonathan M</creatorcontrib><creatorcontrib>Whitfield, Thomas H F</creatorcontrib><creatorcontrib>Starks, Tyrel J</creatorcontrib><creatorcontrib>Grov, Christian</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>Safety Science and Risk</collection><jtitle>Journal of acquired immune deficiency syndromes (1999)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Parsons, Jeffrey T</au><au>Rendina, H Jonathon</au><au>Lassiter, Jonathan M</au><au>Whitfield, Thomas H F</au><au>Starks, Tyrel J</au><au>Grov, Christian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Uptake of HIV Pre-Exposure Prophylaxis (PrEP) in a National Cohort of Gay and Bisexual Men in the United States</atitle><jtitle>Journal of acquired immune deficiency syndromes (1999)</jtitle><addtitle>J Acquir Immune Defic Syndr</addtitle><date>2017-03-01</date><risdate>2017</risdate><volume>74</volume><issue>3</issue><spage>285</spage><epage>292</epage><pages>285-292</pages><issn>1525-4135</issn><eissn>1944-7884</eissn><coden>JDSRET</coden><abstract>OBJECTIVES:The HIV care cascade provides milestones to track the progress of HIV-positive people from seroconversion through viral suppression. We propose a Motivational pre-exposure prophylaxis (PrEP) Cascade involving 5 stages based on the Transtheoretical Model of Change.
METHODS:We analyzed data from 995 men in One Thousand Strong, a longitudinal study of a national panel of HIV-negative gay and bisexual men in the United States.
RESULTS:Nearly all (89%) participants were sexually active in the past 3 months and 65% met Centers for Disease Control criteria for PrEP candidacy. Of those identified as appropriate candidates, 53% were Precontemplative (stage 1; unwilling to take or believing they were inappropriate candidates for PrEP) and 23% were in Contemplation (stage 2; willing and self-identified as appropriate candidates). Only 11% were in PrEParation (stage 3; seeing PrEP as accessible and planning to initiate PrEP) and 4% were in PrEP Action (stage 4; prescribed PrEP). Although few of those who were identified as appropriate candidates were on PrEP, nearly all PrEP users (98%) reported adhering to 4 or more doses per week and most (72%) were returning for recommended quarterly medical visits, resulting in 9% of PrEP candidates reaching Maintenance and Adherence (stage 5).
CONCLUSIONS:The large majority of participants were appropriate candidates for PrEP, yet fewer than 1 in 10 were using and adherent to PrEP. These findings highlight the need for interventions tailored to address the unique barriers men face at each stage of the cascade, particularly at the earliest stages where the most dramatic losses were identified.</abstract><cop>United States</cop><pub>Copyright Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>28187084</pmid><doi>10.1097/QAI.0000000000001251</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1525-4135 |
ispartof | Journal of acquired immune deficiency syndromes (1999), 2017-03, Vol.74 (3), p.285-292 |
issn | 1525-4135 1944-7884 |
language | eng |
recordid | cdi_proquest_miscellaneous_1877828653 |
source | Journals@Ovid Ovid Autoload; MEDLINE; Journals@Ovid LWW Legacy Archive; Free E- Journals |
subjects | Adult AIDS/HIV Gays & lesbians HIV HIV Infections - prevention & control Human immunodeficiency virus Humans Intervention Lentivirus Longitudinal Studies Male Medical treatment Middle Aged Patient Compliance Pre-Exposure Prophylaxis - statistics & numerical data Retroviridae Sexual and Gender Minorities United States |
title | Uptake of HIV Pre-Exposure Prophylaxis (PrEP) in a National Cohort of Gay and Bisexual Men in the United States |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T14%3A04%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Uptake%20of%20HIV%20Pre-Exposure%20Prophylaxis%20(PrEP)%20in%20a%20National%20Cohort%20of%20Gay%20and%20Bisexual%20Men%20in%20the%20United%20States&rft.jtitle=Journal%20of%20acquired%20immune%20deficiency%20syndromes%20(1999)&rft.au=Parsons,%20Jeffrey%20T&rft.date=2017-03-01&rft.volume=74&rft.issue=3&rft.spage=285&rft.epage=292&rft.pages=285-292&rft.issn=1525-4135&rft.eissn=1944-7884&rft.coden=JDSRET&rft_id=info:doi/10.1097/QAI.0000000000001251&rft_dat=%3Cproquest_cross%3E4315397311%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1869877100&rft_id=info:pmid/28187084&rfr_iscdi=true |